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A b s t r A c t
The need for confirmation or exclusion of biological father and / or biological 
mother is a social phenomenon, which is imposed by socio-economic and, some-
times, by moral-psychological factors. Modern science has significantly contrib-
uted to solving this problem, as many medical methods have been applied for this 
purpose. Biological markers that have been conducted for distinguishing between 
individuals were the human ABO blood groups, the Rh, MNS, Duffy, Kidd, and Kell 
systems, as well as the human leukocyte antigens (HLA) system. For a long time the 
HLA testing represented the standard testing in forensic genetics, but, due to the link-
age disequilibrium and the predominance of certain HLA alleles and as the demand 
for parentage investigations is rapidly increasing during the recent years, this serologi-
cal era has been replaced by molecular markers through the introduction of “DNA 
profiling”, which is based on polymorphisms of short tandem repeats (STRs) loci. 
Nowadays, “DNA profiling” by analysis of STR loci is the method of choice for hu-
man identification and parentage investigations. This technique is the most informa-
tive, accurate, robust, rapid, cost-effective method of genotyping and has worldwide 
acceptance in the courts, as the probability of parentage will typically be greater than 
99.99999%.
I N t r O D U c t I O N
Nowadays, most parentage investigations are usually conducted in order to 
establish legal responsibility and support for a child. In addition, several other 
cases are investigated in order to prevent disputes in adoption, in in vitro fertiliza-
tion (IVF) cases, in prenatal diagnosis, in bone marrow transplantation (follow ups), 
as well as cases in which a record for immigration is required.
Historically, the first biological markers used to genetically distinguish between 
individuals were the human ABO blood groups.1 The ABO blood group phenotyping 
was introduced to paternity or maternity assessment very early, but soon it started 
playing a complementary role due to the fact that it is not very informative. While it 
is useful for excluding an individual from the paternity or maternity test, it is not use-
ful when an inclusion is required. When for example, conventional ABO blood group 
typing has a power of exclusion (PE) of only 17%, this value increases to 53% using 
revIew
Immunology and Histocompatibility 
Department, Evagelismos General 
Hospital of Athens, Athens; Greece
HOSPITAL CHRONICLES 2015, 10(2): 83–90
Correspondence to:
Diamanto Kouniaki, PhD, 
Immunology and Histocompatibility 
Department, Evagelismos Hospital, 
Athens, Greece;  
e-mail: kouniakitzeni@yahoo.gr
Manuscript received February 24, 
2015; Revised manuscript received and 
accepted April 22, 2015
KeY wOrDs: parentage testing; 
short tandem repeats (STRs); DNA 
profile; human DNA typing; genetic 
polymorphisms; human leukocyte 
antigens (HLA)
AbbreviAtions
AF(s) = alleged father(s)
CPI = combined paternity index
HLA = human leukocyte antigens
IMGT = international ImMunoGeneTics 
(project)
IVF = in vitro fertilization
MHC = major histocompatibility complex
PCR = polymerase chain reaction
PE = power of exclusion
PI = paternity index
RFLP = fragment length polymorphism
STRs = short tandem repeats
VNTRs = variable number of tandem 
repeats
W = probability of paternity
Conflict of Interest: none declared
84
HOSPITAL CHRONICLES 10(2), 2015
simultaneously the Rh, MNS, Duffy, Kidd, and Kell systems.2
The next methodology that was used to carry out parent-
age investigations was the major histocompatibility complex 
(MHC) system. The MHC system, known as the human leuko-
cyte antigens (HLA) system, is the most polymorphic genetic 
system in human genome and expands to a 3.6 Mb region 
located on the short arm of human chromosome 6 (6.p21.3). 
More than 300 different genes and pseudo-genes have been 
identified in this complex. HLA gene products are expressed 
as glycoprotein heterodimers on the cell surface, specialized 
to present antigenic peptides to the T-Cell Receptor (TCR) 
on T cells.3 The HLA antigens play a fundamental role in im-
mune function, as they control the immune response through 
recognition of “self” and “non-self”.4,5 Regarding the way of 
transmission through generations, the HLA genes are inher-
ited en bloc from each parent due to their close proximity on 
the short arm of human chromosome 6. The set of HLA alleles 
inherited from each one parent is referred to as a haplotype 
and it is transmitted according to Mendelian fashion. HLA 
genes have multiallelic and stable nature with low recom-
bination events, while mutations have not been recorded in 
family studies.6 According to the World Health Organization 
Nomenclature Committee more than 12.200 HLA alleles have 
been documented in the IMGT/HLA database (http://www.
ebi.ac.uk/imgt/hla released 3.18.0, 2014-10-10).7,8 Due to this 
variability, the HLA system has proved to be a useful tool in 
paternity testing. For parentage investigations, incompatibili-
ties in at least one HLA allele between parents and offspring 
indicate exclusion. Many studies have shown that HLA se-
rological markers can provide a PE value greater than 98%, 
while the probability of paternity (W) value can reach 99.99% 
in many cases. However, due to linkage disequilibrium and 
the predominance of certain HLA alleles in particular ethnic 
groups, in some cases the HLA loci are not informative enough 
and do not provide high discrimination power, leading to the 
need for new markers and new methods.9
For a long time the HLA testing represented the stan-
dard procedure in forensic genetics. However, very early in 
the 1990’s, as the demand for higher statistical significance 
increased, this serological era was replaced by molecular 
markers through the introduction of “DNA profiling” based 
on polymorphisms located in the microsatellite regions (details 
of published STR studies http://www.cstl.nist.gov/div831/
strbase). The human genome is full of repeated sequences 
which show widespread allocation more or less throughout 
the human genome, accounting for about 3% of the entire 
genome.10 These tandem repeated sequences are classified, 
according to the length of the core repeat unit and the number 
of repeat unit, into two groups, 1) Variable number of tan-
dem repeats-VNTRs (also called minisatellites), and 2) Short 
tandem repeats-STRs (also called microsatellites). In 1985 
the English geneticist Alec Jeffreys studied the minisatellites 
regions and developed the “DNA fingerprinting” methodo-
logy based on the restriction fragment length polymorphism 
(RFLP) analysis. There are loci with long motifs, ranging from 
8 to 80 bp, and the number of repeat units varies significantly 
between individuals. But, as the demand for identity testing 
increased rapidly, and as they are not amenable to automa-
tion because of their large size, minisatellites were abolished 
and finally replaced by the STR loci analysis (http://www.cstl.
nist.gov/biotech/strbase/seq_ref.htm).11
P A r e N t A G e  t e s t I N G  b A s e D  
O N  “ D N A  P r O F I L I N G ”
Historically, STRs were identified in the early 1980s and 
were first described as an important tool for human identity 
testing in the early 1990s by Alec Jeffreys. STRs loci have been 
widely used in forensic casework since 1993 and, nowadays, 
they are the method of choice for human identification and 
parentage investigations. Microsatellites or STRs or simple 
sequence repeats (SSRs), are non-coding tandem repeat 
units composed of small motifs of 2 to 6 nucleotides (bp) 
repeated typically from 5 to 30 times.12 The length of repeat 
regions is shorter than 100 bp. Most STRs loci are located 
in the non-coding regions, while only about 8% are found in 
intergenic regions. They are believed to have no biological 
uses and regarded as non-functional “junk DNA”. However, 
studies have shown possible correlation between some human 
neurodegenerative disorders, such as Huntington’s disease. 
According to the length of the repeat unit, STRs are classi-
fied into mono-, di-, tri-, tetra-, penta- and hexanucleotide 
repeats, and the most common STRs in the human genome are 
dinucleotide repeats.13 One typical example of a microsatellite 
is the 5’-3’ (TCAT)n marker (named as THO1 with chromo-
somal location 11p15.5, tyrosine hydroxylase 1st intron), where 
n varies between alleles. These hypervariable regions have a 
large number of alleles, depending on the number of repeats, 
showing sufficient variability among individuals in a population 
with high degree of heterozygosity, frequently greater than 
0.7.14 Thus, the probability of two random individuals, except 
identical twins, having exactly the same alleles at each STR loci 
is extremely rare.15 Scientists can use these variable regions to 
create a genotyping of an individual referred to us as a “DNA 
profile”, using samples of blood, bone, hair, saliva, semen and 
other kinds of body tissue and products.16 Although the human 
genome contains thousands of STR markers (~500.000 loci), 
only a small core set of loci has been selected for use in hu-
man identity testing. Their exact chromosomal location only 
recently became available with the completion of the Human 
Genome Project17 (Table 1).
The inheritance of STRs markers follows the basic Men-
delian principles.18 Every individual has a pair of STR alleles, 
one inherited from the mother (maternal origin), and the other 
from the father (paternal origin). There are two possibilities. 
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An individual is either homozygous (having the same number 
of repeats) or heterozygous (having different number of re-
peats) at a particular locus.
However, autosomal microsatellite analysis has certain 
drawbacks. It is known that in vivo the mutation rate of micro-
satellites is much higher, ranging from 10-2 to 10-6 nucleotides 
per locus per generation, than that of other parts of the human 
genome (approximately 10-9 nt per generation). The range 
differs among different loci, and depends on repeat number, 
repeat unit and repeat structure, the composition of the STR, 
recombination, gender and age.19,20 Several mechanisms have 
been proposed to explain the high mutation rate. Among oth-
ers the strand-slippage replication appears to be as the main 
cause of STR mutation, which has also been called DNA 
slippage, polymerase slippage or slipped strand mispairing.21 
In parentage investigation, as well as in human identification, 
the possibility of mutation should be taken into consideration 
when a genetic mismatch is observed, which normally can lead 
to non-inclusion. Nowadays, for the exclusion of an alleged 
father, the “paternal obligate alleles – POA” should not be 
found in the offspring in three or more testing STRs loci.22
In disputed parentage investigations, genetic markers of 
the child, the alleged mother and/or the alleged father are 
compared to determine exclusion or non-exclusion. Ιt should 
be emphasized that medical methods lead to the exclusion 
of the alleged father and/or mother at a certainty of 100% 
or non-exclusion probability at a rate that depends on the 
number of controlled genetic markers and the frequency of 
the alleles encountered in the controlled population. On the 
other hand, proof of paternity or maternity is not possible with 
a 100% certainty because there is always a chance for another 
random individual to have the same genetic blueprint with the 
alleged father (AF) or alleged mother.23 In cases where an 
alleged father is not excluded, mathematical formulas were 
developed for the analysis of parentage using allele frequency 
databases.24 More specifically, the combined paternity index 
tAbLe 1. Locus details and genomic coordinates of commercial markers (17 core loci) routinely employed in paternity/
maternity assessment.
Locus 
designation
chromosome 
location
repeat  
sequence 5’-3’
Alleles included in AmpFlstr® NGM select™ Allelic Ladder†
D10S1248 10q26.3 GGAA 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
vWA 12p13.31 TCTA complex 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
D16S539 16q24.1 GATA 5, 8, 9, 10, 11, 12, 13, 14, 15
D2S1338 2q35 TGCC complex 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
Amelogenin* X:p22.1-22.3
Y:p11.2
NA X, Y
D8S1179 8q24.13 TCTA complex 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
D21S11 21q11.2-q21 TCTA complex 24, 24.2, 25, 26, 27, 28, 28.2, 29, 29.2, 30, 30.2, 31, 31.2, 32, 32.2, 33, 33.2, 34, 34.2, 35, 35.2, 36, 37, 38
D18S51 18q21.33 AGAA 7, 9, 10, 10.2, 11, 12, 13, 13.2, 14, 14.2, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
D22S1045 22q12.3 ATT 8, 9 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
D19S433 19q12 AAGG complex 9, 10, 11, 12, 12.2, 13, 13.2, 14, 14.2, 15, 15.2, 16, 16.2, 17, 17.2
THO1 11p15.5 AATG 4, 5, 6, 7, 8, 9, 9.3, 10, 11, 13.3
FGA 4q28 TTTC complex 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 26.2, 27, 28, 29, 30, 30.2, 31.2, 32.2, 33.2, 42.2, 43.2, 44.2, 45.2, 
46.2, 47.2, 48.2, 50.2, 51.2
D2S441 2p14 TCTA 9, 10, 11, 11.3, 12, 13, 14, 15, 16
D3S1358 3p21.31 TCTA complex 12, 13, 14, 15, 16, 17, 18, 19
D1S1656 1q42.2 TAGA complex 9, 10, 11, 12, 13, 14, 14.3, 15, 15.3, 16, 16.3, 17, 17.3, 18.3, 19.3, 20.3
D12S391 12p13.2 AGAT complex 14, 15, 16, 17, 18, 19, 19.3, 20, 21, 22, 23, 24, 25, 26, 27
SE33 6q14 AAAG complex 4.2, 6.3, 8, 9, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 20.2, 21, 21.2, 22.2, 23.2, 24.2, 25.2, 26.2, 27.2, 28.2, 
29.2, 30.2, 31.2, 32.2, 33.2, 34.2, 35, 35.2, 36, 37
*Amelogenin is not an STR but displays a 106-base, X-specific band and a 112-base, Y-specific band.
†Report published at the U.S. National Institute of Standards and Technology (NIST) web site at: www.cstl.nist.gov/div831/strbase/
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(CPI) and the probability of paternity (W) values are calculated 
using the assigned paternity index (PI) for each tested STR 
marker from a reference population database. PI is a statisti-
cal measure of how powerfully a match at a particular marker 
indicates paternity. The CPI indicates the overall probability 
of an individual being the biological father of the tested child 
as related to any random man from the entire population of 
the same race. The CPI is converted into the W value, show-
ing the degree of relatedness between the AF and the child.25 
Finally, using the STRs procedure in parentage testing, the W 
value can reach the probability factor of 99.999999% or 1 in 
10 billion of the population.26 Ιt should be underlined that 
“DNA profile” cannot distinguish the true biological father 
only in cases where the two alleged fathers are monozygotic 
twins. On the other hand, in mutation events, where there are 
only one or two mismatches, the PI value at a single or double 
mismatching genetic locus is not documented as zero, but shall 
be modified using equations that incorporate the mutation rate 
at the specified genetic loci.27
To date, several countries have legislated to implement 
national DNA databases based on STRs.28 The National 
Institute of Standards and Technology (NIST) of the USA 
has compiled and maintained an STR DNA internet data-
base available at http://www.cstl.nist.gov/biotech/strbase/ 
commonly referred to as STRBase. On the other hand, 
statistical analyses were conducted by several programs such 
as STATCEL (OMSPublishing Inc.), Powerstats version 1.2 
(Promega Corp.) and OmniPop (http://www.cstl.nist.gov/
biotech/strbase/population/OmniPop). Additionally, there 
are several programs for creating pedigrees and calculating 
the W value, such as the Familias program (download free 
at http://www.nr.no/familias).
L e G A L  I s s U e s  I N  P A r e N t A G e  t e s t I N G
DNA testing is a necessary tool in family law. Apart from 
cases that might relate to people concerned, there are many 
cases, which fall within the field of civil law (e.g. cases of 
recognition of illegitimate children, waivering paternity of 
a child born in wedlock) or criminal law (e.g. rape, incest, 
abandonment and abuse of pregnant woman), where the 
test is performed after a court order and the judge appoints 
a special expert.
A lot of countries have restrictions/regulations on human 
DNA testing regarding the principles of blood sampling, 
processing, testing and the statistical analysis of the data. For 
judicial recognition of paternity, the experts appointed by 
the court must use the most appropriate medical tests and 
methods which must be internationally admissible and not 
at the stage of experimentation and they must follow the 
rules of the procedure strictly. A report of the statistical 
significance of a match must be submitted by the expert.
Many organizations around the world work on a national 
or international level in order to aid in quality assurance 
work, such as the Technical Working Group on DNA analysis 
Methods (TWGDAM), the European Network of Forensic 
Science Institutes (ENFSI) and the European DNA Profiling 
Group (EDNAP). Internationally, there are also several 
organizations responsible for the definition of relevant stan-
dards, as well as organizations responsible for the relevant 
accreditation. Authorized accreditation organizations 
around the world comprise among others, the College of 
American Pathology (CAP), the New York State Depart-
ment of Health-Standards (NYSDOH) for Parentage Testing 
Laboratories (www.wadsworth.org/labservices.htm), the 
Standards Council of Canada (SCC), the American Society 
of Crime Laboratory Directors/Laboratory Accreditation 
Board (ASCLD/LAB) - International, the Department for 
Constitutional Affairs (DCA) and the American Association 
of Blood Bank (AABB).29
b r I e F  D e s c r I P t I O N  O F  t H e  M e t H O D
The complete process for STR typing includes:
 1. Sample collection and DNA extraction; a testing method 
requires whole blood in EDTA tubes or blood drops 
from finger/heel pricks taken onto paper stain cards 
(bloodstained FTA cards) and/or buccal swabs of saliva. 
Samples of swab saliva are obtained from the inside of the 
mouth with cotton or dacron swabs and this can be done 
immediately after birth. The DNA extraction procedure 
is either automatic or manual.
 2. Polymerase chain reaction (PCR) setup and DNA ampli-
fication of multiple STR loci; samples are co-amplified 
with four fluorescence-labeled primers in a multiplex 
PCR system. Commercial autosomal STR genotyping kits 
are commonly used in paternity testing. For instance, the 
AmpFlSTR NGM SELectTM (Applied Biosystems, Foster 
City, CA) and the PowerPlexTM16 kits (Promega, Madison, 
WI, Technical Manual PowerPlex®16 HS System www.
promega.com.) are able to type 16 and 15 autosomal STR 
loci respectively with high discrimination power.
 3. STR allele separation and DNA sizing; amplified STR 
fragments are generally separated on the capillary based 
automated DNA sequencers like ABI PRISM 310, ABI 
PRISM 3100/3730xl DNA Sequencer systems, MegaBase 
1000/500 of Amersham Pharmacia Biotech, USA and 
Beckman Coultier CEQ 2000XL DNA Sequencer. PCR 
products of all tested STR loci with overlapping size ranges 
can be easily distinguished by size and detected with high 
resolution due to the different characteristic emission 
spectrum of each fluorescence dye.30
 4. STR typing and profile interpretation; analysis of the re-
sults obtained by the previous step is carried out following 
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the guidelines and recommendations of the DNA Com-
mission of the International Society of Forensic Genetics 
(ISFG) and the European DNA profiling (EDNAP) group. 
To produce the genotyping chromatogram, the GeneMap-
per® ID V3.2, GeneScan® 3.7 or Genotyper® 3.7 softwares 
for automatic allele calling (Applied Biosystems, Foster 
City CA) are used and all alleles are represented as peaks 
(Fragment Analysis).31 A sample typing showing two alleles 
(two peaks in the electropherogram) indicate heterozygo-
sity, whereas one allele (one peak in the electropherogram) 
indicate homozygosity at a particular locus (Fig. 1).
 5. A report of the probability of the respective parenthood 
is performed by the expert.
The process of recording and archiving of samples as 
well as the privacy procedure are carried out following the 
guidelines of the human and ethical research principles.
O t H e r  c O N t e M P O r A r Y  D N A  M A r K e r s 
I N  F O r e N s I c  I N v e s t I G A t I O N s
1 .  Y  c H r O M O s O M A L  P O LY M O r P H I s M
In the past 15 years, the use of Y-Chromosome STR loci 
has seen tremendous increase in forensic as well as in paternity 
investigations. The Y chromosome has stable nature, is found 
only in males and it is transmitted from father to son without 
mutations. For identity testing, although Y chromosome 
markers have been extensively used in genetic genealogy stud-
ies as well as in cases of sexual assaults, they are considered 
inappropriate to use so as to distinguish men belonging to 
the same pedigree. For disputed paternity testing, Y-Chro-
mosome STR markers are a useful tool in cases where the 
alleged father is not available, but another person through 
paternal lineage is available (Y-STR database http://www.
cstl.nist.gov/biotech/strbase/y_strs.htm).32
2 .  M I t O c H O N D r I A L  D N A  ( M t D N A )  s e q U e N c I N G
Another system that has been studied for identification 
purposes is the mitochondrial DNA (mtDNA). MtDNA mark-
ers are diallelic polymorphic loci. They are passed en bloc to 
the next generation and inherited from the mother only and 
not from the father.33 Thus, while they are suitable to evaluate 
maternal relatedness or kinships, they cannot be applied for 
establishing paternity testing (Human mitochondrial genome 
database available at http://www.mitomap.org).
3 .  s I N G L e  N U c L e O t I D e  P O LY M O r P H I s M s 
( s N P s )
Other types of genetic variations applied in parentage 
investigations are variations of single nucleotide polymor-
phisms (SNPs). According to recent studies, these diallelic 
polymorphic loci are considered to be a useful tool in dis-
puted paternity or maternity assessment due to the fact that 
they have easy application, low cost, but mainly because they 
have very low mutation rate (100,000 times lower compared to 
STRs loci).34 However, in order to achieve the same statistical 
significance as that of STRs, a panel of 40 short insertion-
deletion polymorphisms is required for an efficient human 
FIGUre 1. Map of genotyping of 17 STR loci. Each peak on the electropherogram represents a fluorescently labeled DNA fragment 
that indicates the maternal or paternal allele. The vWA, D16S539, D21S11, D18S51, D19S433, TH01, FGA, D2S441, D3S1358, 
D1S1656, D12S391 and SE33 loci are heterozygous, whereas the D10S1248, D2S1338, D8S1179 and D22S1045 loci are homozygous. 
This sample is from female as indicated by one peak for the amelogenin (ID:38364).
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parentage testing. It is considered that in the future it will be 
a very promising tool for conducting disputed paternity or 
maternity testing35 (SNPs database available at http://www.
ncbi.nlm.nih.gov/projects/SNP/).
c O N c L U s I O N s
The STR genotyping has become an important tool for 
human identity testing and has increased our ability to solve 
problems of family relationships and kinships, providing highly 
sufficient power of discrimination. The high polymorphism, 
heterozygosity, co-dominance and distribution over the 
eukaryotic genome have made microsatellites the markers 
of choice for the construction of genetic maps, population 
genetics and forensics as well as for parentage investigations. 
Additionally, the remarkable advances in DNA technologies 
over the past two decades have had an enormous impact on the 
development of the “DNA profile” for human identification. 
Specifically, the availability of capillary sequencers and laser 
based technology provides a high sample throughput. DNA 
markers can be easily amplified by a single PCR, even in cases 
that involve degraded DNA. Commercial STR kits permit reli-
able amplification of these unlinked loci from small amounts of 
starting DNA template, using less than 1 ng of genomic DNA 
and can recover information even at the level of a single cell.
In the past, identification procedures, such as the ABO 
blood group antigens, serum proteins and RBC enzymes, had 
the disadvantage of poor power of discrimination due to low 
polymorphism and poor sensitivity and carried the risk of giv-
ing false paternity inclusions, especially when the mother was 
not available. On the other hand, VNTR loci have excellent 
powers of discrimination due to the large number of alleles 
at each locus but bear limited sensitivity, are time-consuming 
and cannot be automated. Additionally, due to the predomi-
nance of certain HLA alleles and linkage disequilibrium, in 
some cases HLA genotyping was not informative enough and 
therefore the statistical power of W was low.36
Today, STRs genotyping has completely replaced the HLA 
typing in paternity investigations. STR profile can overcome 
the limitations of the HLA system and it is believed that 
due to high variability, excellent power of discrimination and 
automated detection, which enable high-throughput sample 
processing, it will continue to be in use for many years to come. 
However, the mutation rate of STR loci is higher than that 
of the HLA or some other genetic markers (Fig. 2). Thus, ac-
FIGUre 2. One genetic discrepancy between the biological father (ID:38501) and the child (ID:38504SWAB) was observed in vWA 
STR locus (Putative mutation: vWA 19→18 or 16→18). Biological mother (ID:38503). Paternity is not excluded.
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cording to global instructions, in order to avoid the risk of 
falling into a false exclusion of the biological father of the 
child, the alleged father has to be genetically inconsistent 
with the child at two or more of the analyzed STR loci. Ad-
ditionally, in cases when the DNA profile of the mother is not 
available (motherless cases), the W value is lower than in trio 
cases (alleged father, mother and child) and the difference 
gets even more significant when the number of STR markers 
is limited and the allele frequency is high.37 For this reason, 
global guidelines suggest that the number of the tested ge-
netic STRs markers should be increased from 16-17 to 21.38 
On the other hand, in motherless cases with mutation events, 
more genetic information and more attention to the statistical 
analyses is required. Thus, it is recommended that the mother 
should be investigated in all cases.39 When this is not possible, 
another genetic system can be used as a supplementary tool, in 
order to lessen the possibility of false exclusion due to mutation 
events and reliable results to be achieved.
The use of STRs markers in paternity/maternity assessment 
has been introduced in the Department of Immunology and 
Histocompatibility of Evagelismos General Hospital of Athens 
since 2012 and it is in routine practice for solving problems 
such cases.
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